All lobbying filings

THE MCMANUS GROUP

Lobbying for BRISTOL-MYERS SQUIBB · Biopharmaceutical Company

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $80,000.00 income · posted Apr 20, 2026

Official filing document

Bills named in this filing 1

HR 4299
Protecting Patient Access to Cancer and Complex Therapies Act

Lobbying activity 1

Medicare/Medicaid

Policies related to the Most Favored Nation Drug Pricing Model Implementation of provisions included in Subtitle B of PL.117-169-Inflation Reduction Act of 2022. H.R.4299 - Protecting Patient Access to Cancer and Complex Therapies Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.